Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
3.580
-0.040 (-1.10%)
May 15, 2026, 4:00 PM EDT - Market closed

Myriad Genetics Revenue

Myriad Genetics had revenue of $200.40M in the quarter ending March 31, 2026, with 2.30% growth. This brings the company's revenue in the last twelve months to $829.00M, down -0.28% year-over-year. In the year 2025, Myriad Genetics had annual revenue of $824.50M, down -1.56%.

Revenue (ttm)
$829.00M
Revenue Growth
-0.28%
P/S Ratio
0.41
Revenue / Employee
$307,037
Employees
2,700
Market Cap
338.12M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025824.50M-13.10M-1.56%
Dec 31, 2024837.60M84.40M11.21%
Dec 31, 2023753.20M74.80M11.03%
Dec 31, 2022678.40M-12.20M-1.77%
Dec 31, 2021690.60M133.50M23.96%
Dec 31, 2020557.10M-81.50M-12.76%
Jun 30, 2020638.60M-212.50M-24.97%
Jun 30, 2019851.10M107.40M14.44%
Jun 30, 2018743.70M15.00M2.06%
Jun 30, 2017728.70M-11.80M-1.59%
Jun 30, 2016740.50M17.40M2.41%
Jun 30, 2015723.10M-55.10M-7.08%
Jun 30, 2014778.20M165.00M26.91%
Jun 30, 2013613.20M117.20M23.63%
Jun 30, 2012496.01M93.92M23.36%
Jun 30, 2011402.08M39.44M10.87%
Jun 30, 2010362.65M36.12M11.06%
Jun 30, 2009326.53M103.67M46.52%
Jun 30, 2008222.86M77.57M53.39%
Jun 30, 2007145.29M31.01M27.13%
Jun 30, 2006114.28M31.87M38.68%
Jun 30, 200582.41M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
NeoGenomics745.97M
OPKO Health581.12M
CareDx412.82M
Castle Biosciences339.92M
Fulgent Genetics320.35M
FONAR105.34M
Biodesix96.10M
Prenetics Global92.39M
Revenue Rankings